8-KLeadership ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Executive Changes (Sep 20, 2006)

Filed September 20, 2006For Securities:CVS

Summary

CVS Health Corporation (CVS) filed an 8-K report on September 20, 2006, to announce a significant change in its Board of Directors. Richard J. Swift was elected to the Board and appointed to the Audit Committee. Mr. Swift's extensive financial and leadership background, including his former role as Chairman and CEO of Foster Wheeler Ltd. and his tenure on the Financial Accounting Standards Advisory Council (FASAC), brings valuable expertise to CVS. This appointment signals a strengthening of the company's governance and financial oversight, particularly within its audit function. Investors should view this as a positive development, indicating CVS's commitment to robust financial reporting and board-level financial acumen. The press release detailing this appointment is attached as an exhibit to this filing.

Key Highlights

  • 1Richard J. Swift elected to the CVS Corporation Board of Directors as of September 20, 2006.
  • 2Mr. Swift appointed to the Audit Committee of the Board of Directors.
  • 3Mr. Swift designated as an "audit committee financial expert," highlighting his accounting and auditing expertise.
  • 4Mr. Swift's prior experience includes serving as Chairman, President, and CEO of Foster Wheeler Ltd.
  • 5Mr. Swift has significant experience with the Financial Accounting Standards Advisory Council (FASAC), having served as its Chairman.
  • 6The company issued a press release on September 20, 2006, to announce this board appointment.

Frequently Asked Questions